Screener
Phibro Animal Health Corporation PAHC Ratios & Valuation
| Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 33.8%+2.9pp | 32.5%+0.9pp | 31.9%+0.1pp | 31.2%-0.3pp | 30.9%+0.1pp | |
| Operating margin | 12.8%+4.3pp | 12%+4.0pp | 11.5%+4.2pp | 10.3%+3.4pp | 8.5%+3.3pp | |
| Net margin | 6.6%+2.8pp | 6.3%+3.7pp | 6.3%+4.5pp | 4.8%+3.2pp | 3.7%+3.5pp | |
| Returns | ||||||
| Return on equity | 29.7%+11.9pp | 30.3%+18.5pp | 31.8%+24.3pp | 23.8%+17.2pp | 17.8%+16.9pp | |
| Return on invested capital | 43%+13.4pp | 46.7%+20.6pp | 48.3%+28.6pp | 42.3%+26.3pp | 29.6%+19.9pp | |
| Efficiency | ||||||
| Asset turnover | 1.1×0.0× | 1.1×0.0× | 1.1×+0.1× | 1.2×+0.1× | 1.1×+0.1× | |
| Liquidity | ||||||
| Current ratio | 3×+0.2× | 3.2×+0.3× | 3.1×-0.1× | 3.1×-0.1× | 2.8×-0.2× | |
| Leverage | ||||||
| Debt-to-equity | 0.1×-0.1× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.2×-0.1× | |
| Net debt / EBITDA | -0×0.0× | -0.1×+0.2× | -0.1×+0.2× | -0.2×+0.1× | -0.1×0.0× | |
| Per Share | ||||||
| Book value per share | $9.41+34.0% | $8.82+34.9% | $8.12+33.9% | $7.62+19.7% | $7.02+10.9% | |
| Valuation | ||||||
| Market capitalization | $1.52B+0.8% | $2.24B+159% | $1.51B+78.0% | $1.64B+79.8% | $1B+47.8% | |
| Price / earnings | 15.2×-7.0× | 23.5×-3.7× | 16.4×-27.6× | 24.2×-28.2× | 20.8×-260× | |
| Price / sales | 1×-0.1× | 1.5×+0.8× | 1×+0.3× | 1.2×+0.3× | 0.8×+0.1× | |
| Price / book | 3.9×-0.9× | 6.2×+2.9× | 4.6×+1.1× | 5.3×+1.7× | 3.5×+0.9× | |
| EV / EBITDA | 6.2×-1.4× | 9.6×+3.6× | 6.8×+0.1× | 8.2×+0.1× | 6.4×-1.2× | |
| Dividend yield | 1.3%0.0pp | 0.9%-1.4pp | 1.3%-1.0pp | 1.2%-0.9pp | 1.9%-0.9pp |
FAQ
- What are Phibro Animal Health Corporation's profit margins?
- Phibro Animal Health Corporation (PAHC) runs a 33.8% gross margin and a 12.8% operating margin, with a 6.6% net margin.
- Where do Phibro Animal Health Corporation's ratios come from?
- Every ratio is computed from Phibro Animal Health Corporation's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
